IRIS
MIMMI, SELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.036
AS - Asia 1.238
EU - Europa 873
SA - Sud America 183
AF - Africa 24
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.956
SG - Singapore 634
IT - Italia 455
CN - Cina 278
BR - Brasile 150
DE - Germania 127
IN - India 105
VN - Vietnam 100
FI - Finlandia 62
CA - Canada 59
SE - Svezia 59
GB - Regno Unito 50
HK - Hong Kong 33
FR - Francia 22
KR - Corea 14
ES - Italia 13
MX - Messico 13
NL - Olanda 13
PL - Polonia 12
ID - Indonesia 11
ZA - Sudafrica 11
AR - Argentina 10
RO - Romania 10
BD - Bangladesh 9
JP - Giappone 9
CZ - Repubblica Ceca 8
UA - Ucraina 8
RU - Federazione Russa 7
CO - Colombia 6
IQ - Iraq 6
PK - Pakistan 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
EC - Ecuador 4
GR - Grecia 4
NP - Nepal 4
PT - Portogallo 4
SA - Arabia Saudita 4
VE - Venezuela 4
AT - Austria 3
CL - Cile 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
JO - Giordania 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PW - Palau 1
PY - Paraguay 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 4.362
Salva come PNG Salva come JPEG
Città #
San Jose 344
Dallas 318
Singapore 268
Ashburn 183
Chandler 164
Munich 92
Santa Clara 90
Catanzaro 84
Bengaluru 73
Hefei 73
Milan 66
Lawrence 59
Princeton 59
Beijing 52
Turku 48
Ho Chi Minh City 38
Ottawa 31
Wilmington 31
Hong Kong 30
London 29
Seattle 29
Boardman 26
Chicago 19
Des Moines 19
Rome 19
Los Angeles 18
Hanoi 16
São Paulo 16
Taranto 15
Napoli 14
Brooklyn 13
Helsinki 13
Montreal 12
Shanghai 11
Augusta 9
Naples 9
Paris 9
Redmond 9
New York 8
Olomouc 8
Redwood City 8
Foggia 7
Seoul 7
Amsterdam 6
Guangzhou 6
Haiphong 6
Johannesburg 6
Marano 6
Modena 6
Norwalk 6
Stockholm 6
Warsaw 6
Atlanta 5
Buffalo 5
Chennai 5
Council Bluffs 5
Frankfurt am Main 5
Hanover 5
Providence 5
Pune 5
Rio de Janeiro 5
San Francisco 5
Teresina 5
The Dalles 5
Boston 4
Da Nang 4
Edmonton 4
Heidesheim 4
Huế 4
Lahore 4
Latina 4
Madrid 4
Padova 4
Palermo 4
Reggio Calabria 4
Shenzhen 4
Tokyo 4
Toronto 4
Târgu Mureş 4
Washington 4
Xi'an 4
Can Tho 3
Caserta 3
Chieti 3
Columbus 3
Crosia 3
Derby 3
Dubai 3
Felgueiras 3
Ferrara 3
Florence 3
Huddinge 3
Istanbul 3
Lamezia Terme 3
Las Vegas 3
Louisville 3
Manchester 3
Mexico City 3
Mumbai 3
Pagani 3
Totale 2.685
Salva come PNG Salva come JPEG
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 148
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 118
A Candidate multi-targeting approach to block the CD98hc oncoprotein 106
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 102
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 95
A novel phage display based platform for exosome diversity characterization 92
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 88
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 85
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 84
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 83
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 82
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 81
PEPTIDI E LORO USI 80
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 80
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 77
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 76
Crucial role for IBtk in the survival and maintenance of mature B cells 75
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 74
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 73
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 73
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 68
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 68
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 67
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 67
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 67
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 63
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 62
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 61
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 60
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 60
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 59
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 59
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 59
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 58
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 58
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 58
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 58
Phage Display: An Overview in Context to Drug Discovery 57
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 56
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 56
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 55
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 55
PEPTIDE AND USES THEREO 55
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 54
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 54
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 54
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 54
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 52
Phage Display: An Overview in Context to Drug Discovery 52
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 52
Belantamab mafodotin in multiple myeloma 51
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 51
Insights into Thymus Development and Viral Thymic Infections 50
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 50
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 47
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 47
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 47
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 44
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 43
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 42
Peptide-guided targeting of GPR55 for anti-cancer therapy. 42
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 39
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 35
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 32
Isatuximab in multiple myeloma 30
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 29
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 29
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 28
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 27
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 26
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 26
Peptide-guided targeting of GPR55 for anti-cancer therapy 25
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 18
null 6
null 2
Totale 4.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 37 18 10
2021/2022266 6 2 13 56 20 12 15 60 19 34 27 2
2022/2023552 120 26 37 23 50 37 7 53 107 38 41 13
2023/2024304 58 37 31 23 21 63 4 9 6 6 17 29
2024/20251.026 128 37 45 37 96 102 27 25 142 25 145 217
2025/20261.993 148 216 361 214 213 99 262 120 242 118 0 0
Totale 4.464